Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mcpherson’S Limited ( (AU:MCP) ) has shared an update.
McPherson’s Limited has warned that its earlier expectation of moderate year-on-year growth in underlying FY26 EBITDA will not be met, as sales under its stabilising new operating model have been weaker than anticipated and suppliers have introduced surcharges in response to macroeconomic cost pressures. Despite this downgrade, the company still expects FY26 EBITDA to be weighted toward the second half, notes it retains a strong balance sheet with a net cash position, and plans to proceed with its previously announced share buy-back, signalling confidence in its long-term strategy and prospects.
Management is prioritising further embedding of the new operating model, with a particular focus on optimising the supply chain and improving in-store product availability to support future performance. The decision to continue the buy-back in the face of near-term earnings pressure suggests McPherson’s is positioning itself for a longer-term recovery, which may reassure investors about balance sheet strength and strategic direction even as short-term profitability expectations are tempered.
More about Mcpherson’S Limited
McPherson’s Limited is an Australian supplier of essential health and beauty products, with a portfolio built around five core household brands: Manicare, Swisspers, Lady Jayne, Dr. LeWinn’s and Fusion Health. The company focuses on growing these brands through pharmacy, grocery, health food and e-commerce channels, and is headquartered in Sydney with a listing on the Australian Securities Exchange.
Average Trading Volume: 310,823
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$23.03M
For an in-depth examination of MCP stock, go to TipRanks’ Overview page.